WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Sodium Management in Acute Neurological Injury

Completed

Conditions: This Study is to Understand the Current Practice of Sodium Management in Acute Neurological Injury

First Posted Date: 2012-03-20

Last Posted Date: 2019-05-01

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 400

Registration Number: NCT01558843

Locations: 🇺🇸
Columbia University, New York, New York, United States
🇺🇸
UK Healthcare, Lexington, Kentucky, United States
🇺🇸
Memorial University Medical Center, Savannah, Georgia, United States

and more 14 locations

Lapatinib With Trastuzumab in Treating Patients With HER2-Negative/HER2 Mutant Metastatic Breast Cancer

Phase 2

Withdrawn

Conditions: Breast Neoplasms

Interventions: Drug: lapatinib ditosylate
Biological: trastuzumab

First Posted Date: 2012-03-19

Last Posted Date: 2013-07-04

Lead Sponsor: Washington University School of Medicine

Registration Number: NCT01557764

Phase I/II Study of Abraxane in Recurrent and Refractory Lymphoma

Phase 1

Terminated

Conditions: Lymphoma, Non-Hodgkin
Hodgkin Disease

Interventions: Drug: Abraxane

First Posted Date: 2012-03-16

Last Posted Date: 2016-12-06

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 20

Registration Number: NCT01555853

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States
🇺🇸
St. Louis University School of Medicine, St. Louis, Missouri, United States

Five Versus Seven Day Antibiotic Course for the Treatment of Pneumonia in the Intensive Care Unit

Not Applicable

Completed

Conditions: Pneumonia, Bacterial

Interventions: Other: 5 Days of Antibiotics
Other: 7 Days of Antibiotics therapy for pneumonia

First Posted Date: 2012-03-15

Last Posted Date: 2012-03-15

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 46

Registration Number: NCT01554657

Low Dose Rituximab in Thrombotic Thrombocytopenic Purpura

Phase 2

Completed

Conditions: Thrombotic Thrombocytopenic Purpura

Interventions: Biological: rituximab

First Posted Date: 2012-03-15

Last Posted Date: 2021-08-17

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 19

Registration Number: NCT01554514

Locations: 🇺🇸
Emory University, Atlanta, Georgia, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Washington University, Saint Louis, Missouri, United States

and more 1 locations

GSK1120212 in Surgically Resectable Oral Cavity Squamous Cell Cancer

Phase 2

Completed

Conditions: Neoplasms, Oral
Mouth Neoplasms

Interventions: Drug: GSK1120212

First Posted Date: 2012-03-14

Last Posted Date: 2016-12-26

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 20

Registration Number: NCT01553851

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

Neuroprotective Effects of Lithium in Patients With Small Cell Lung Cancer Undergoing Radiation Therapy to the Brain

Phase 1

Completed

Conditions: Small Cell Lung Carcinoma

Interventions: Drug: Lithium Carbonate
Radiation: Prophylactic cranial irradiation

First Posted Date: 2012-03-14

Last Posted Date: 2018-07-05

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 19

Registration Number: NCT01553916

Locations: 🇺🇸
Washinton University School of Medicine, Saint Louis, Missouri, United States

Fidaxomicin to Prevent Clostridium Difficile Colonization

Phase 4

Withdrawn

Conditions: Clostridium Difficile Infection

Interventions: Drug: Placebo
Drug: Fidaxomicin

First Posted Date: 2012-03-13

Last Posted Date: 2014-05-28

Lead Sponsor: Washington University School of Medicine

Registration Number: NCT01552668

Locations: 🇺🇸
Washington University in St. Louis, St. Louis, Missouri, United States

Nutributter Programming to Prevent Undernutrition: an Evaluation

Not Applicable

Completed

Conditions: Undernutrition

Interventions: Dietary Supplement: Nutributter Program
Other: Integrated Package

First Posted Date: 2012-03-13

Last Posted Date: 2018-08-06

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 1228

Registration Number: NCT01552512

Locations: 🇭🇹
Hopital Fort San Michel, Cap Haitien, Haiti

Effectiveness of Sitagliptin for HIV Insulin Resistance and Inflammation

Phase 3

Completed

Conditions: Inflammation
Cardiovascular Disease
Macrophage Infiltration

Interventions: Drug: Placebo
Drug: Sitagliptin

First Posted Date: 2012-03-13

Last Posted Date: 2018-05-08

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 38

Registration Number: NCT01552694

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy